Leveraging Patient-Derived Explant Models & Complementary Tumor Models to Supercharge ADC Development
- Demonstrating the pros and cons of explants and other applied models in developing ADCs and dissecting their translational relevance
- Highlighting strategies to implement intact patient tumor explants to retain 3D architecture and the native microenvironment
- Building a full picture for strategic ADC development by combining data from multiple models to identify biomarkers, predict patient response and empower translation to the clinic